Our Science

Held to the standard of medicine, not software

Pear develops therapeutics that are clinically validated, regulated, and prescribed — then measured in the real world.

Clinical validation

Our therapeutics are evaluated in clinical studies with pre-specified endpoints, so clinicians can judge them on evidence rather than engagement metrics alone.

Regulatory clearance

reSET® is FDA-cleared. For each pipeline program, Pear intends to pursue FDA clearance before the therapeutic becomes available by prescription.

Integration with existing care

Rather than competing with pharmacotherapy, our software is designed to be layered onto previously approved pharmaceuticals and established treatment paradigms.

Measurement and outcomes

Digital delivery captures adherence and engagement data that supports outcomes reporting for clinicians, health systems, and payers.

What makes a therapeutic a prescription digital therapeutic

  • It delivers a clinically-validated therapy — not general wellness content.
  • It is authorized by a regulator for a specific indication and patient population.
  • It is obtained through a clinician's prescription and used under clinical oversight.
  • It is designed to work with, and be reimbursed alongside, existing standards of care.